Chandler Robinson, CEO: Monopar Therapeutics MNPR Sell · Filed 09/28

Trade details

Type: Insider sale
Amount: $744,500.96
Shares · price: 8,368 sh · $88.97 a share
Held after: 99,867 sh
Stock: Monopar Therapeutics MNPR
Person: Chandler RobinsonCEO
Trade date: 26/09/24
Filed: 26/09/28
Days to filing: 4 days

Sold 7.7% of holdings

Share of holding sold: 7.7%

Monopar Therapeutics trades, last 26 weeks

What else happened in Monopar Therapeutics around then

Filed or reported within 30 days of the trade day · 08/25~10/24

Chandler Robinson's recent trades

Chandler RobinsonCEO
Sell10b5-1 planMonopar Therapeutics
Sell10b5-1 plan
Monopar Therapeutics
MNPR
$910.7K
10,450 sh
$910.7K
Filed 09/28
Traded 09/24
Chandler RobinsonCEO
Sell10b5-1 planMonopar Therapeutics
Sell10b5-1 plan
Monopar Therapeutics
MNPR
$847.8K
9,638 sh
$847.8K
Filed 09/28
Traded 09/24
Chandler RobinsonCEO
Sell10b5-1 planMonopar Therapeutics
Sell10b5-1 plan
Monopar Therapeutics
MNPR
$53.9K
600 sh
$53.9K
Filed 09/28
Traded 09/24
Chandler RobinsonCEO
Planned sale10b5-1 planMonopar Therapeutics
Planned sale10b5-1 plan
Monopar Therapeutics
MNPR
$2.6M
29,056 sh
$2.6M
Filed 09/24
Traded 09/24
Chandler RobinsonOther
SellMonopar Therapeutics
Sell
Monopar Therapeutics
MNPR
$35M
550,229 sh
$35M
Filed 25/09/26
Traded 25/09/24